Zoetis Inc expected to post earnings of $1.86 a share - Earnings Preview
Zoetis Inc expected to post earnings of $1.86 a share - Earnings Preview
Zoetis Inc ZTS.N, ZTS is expected to show a rise in quarterly revenue when it reports results on August 6 for the period ending June 30 2026
The Parsippany New Jersey-based company is expected to report a 1.7% increase in revenue to $2.502 billion from $2.46 billion a year ago, according to the mean estimate from 12 analysts, based on LSEG data.
LSEG's mean analyst estimate for Zoetis Inc is for earnings of $1.86 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy," 10 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Zoetis Inc is $99.00, about 28.4% above its last closing price of $77.10
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2026 | 1.62 | 1.61 | 1.53 | Missed | -5.2 |
Dec. 31 2026 | 1.40 | 1.40 | 1.48 | Beat | 5.6 |
Sep. 30 2025 | 1.62 | 1.62 | 1.70 | Beat | 4.8 |
Jun. 30 2025 | 1.62 | 1.62 | 1.76 | Beat | 8.8 |
Mar. 31 2025 | 1.40 | 1.39 | 1.48 | Beat | 6.2 |
Dec. 31 2024 | 1.34 | 1.34 | 1.40 | Beat | 4.7 |
Sep. 30 2024 | 1.45 | 1.46 | 1.58 | Beat | 8.6 |
Jun. 30 2024 | 1.48 | 1.49 | 1.56 | Beat | 4.9 |
This summary was machine generated August 4 at 13:44 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Zoetis
See all newsBrief: Zoetis Receives FDA Approval For Convenia® Rtu For Dogs (Cefovecin Injectable Suspension), Helping More Medium And Large Dogs Access Single-Injection Treatment
Brief: FDA Approves Ready-To-Use Cefovecin Injectable For Treatment Of Certain Skin Infections In Dogs
U.S. RESEARCH ROUNDUP-Masco, Sherwin-Williams, Vulcan Materials
Zoetis gets US FDA emergency use nod for treatment for screwworm in dogs
Brief: FDA Issues Emergency Use Authorization For Simparica Trio To Treat New World Screwworm In Dogs, Puppies